Chongkundang Possible Scenario with H&SClearly shows H&S, and personally think the market has shifted to bear market. Could potential bounce at the support area.
Could price drop to 75000 - 84000 won.
Chong Kun Dang Pharmaceutical Corp.
No trades
4,500 KRW
108.44 B KRW
1.59 T KRW
6.34 M
About Chong Kun Dang Pharmaceutical Corp.
Sector
Industry
CEO
Young-Ju Kim
Website
Headquarters
Seoul
Founded
2013
Identifiers
2
ISINKR7185750007
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetic, antivirus, beta-blocking, anti-hyperlipidemia and others. The company was founded on November 5, 2013 and is headquartered in Seoul, South Korea.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 185750 is 87,000 KRW — it has increased by 0.69% in the past 24 hours. Watch Chong Kun Dang Pharmaceutical Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange Chong Kun Dang Pharmaceutical Corp. stocks are traded under the ticker 185750.
185750 stock has fallen by −2.36% compared to the previous week, the month change is a −0.57% fall, over the last year Chong Kun Dang Pharmaceutical Corp. has showed a 0.16% increase.
We've gathered analysts' opinions on Chong Kun Dang Pharmaceutical Corp. future price: according to them, 185750 price has a max estimate of 120,000.00 KRW and a min estimate of 100,000.00 KRW. Watch 185750 chart and read a more detailed Chong Kun Dang Pharmaceutical Corp. stock forecast: see what analysts think of Chong Kun Dang Pharmaceutical Corp. and suggest that you do with its stocks.
185750 reached its all-time high on Dec 21, 2020 with the price of 224,900 KRW, and its all-time low was 36,700 KRW and was reached on Jan 21, 2015. View more price dynamics on 185750 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
185750 stock is 1.04% volatile and has beta coefficient of 0.29. Track Chong Kun Dang Pharmaceutical Corp. stock price on the chart and check out the list of the most volatile stocks — is Chong Kun Dang Pharmaceutical Corp. there?
Today Chong Kun Dang Pharmaceutical Corp. has the market capitalization of 1.15 T, it has decreased by −0.46% over the last week.
Yes, you can track Chong Kun Dang Pharmaceutical Corp. financials in yearly and quarterly reports right on TradingView.
Chong Kun Dang Pharmaceutical Corp. revenue for the last quarter amounts to 427.40 B KRW, despite the estimated figure of 428.57 B KRW. In the next quarter, revenue is expected to reach 428.05 B KRW.
185750 net income for the last quarter is 20.10 B KRW, while the quarter before that showed 19.07 B KRW of net income which accounts for 5.44% change. Track more Chong Kun Dang Pharmaceutical Corp. financial stats to get the full picture.
Yes, 185750 dividends are paid annually. The last dividend per share was 1.10 K KRW. As of today, Dividend Yield (TTM)% is 1.20%. Tracking Chong Kun Dang Pharmaceutical Corp. dividends might help you take more informed decisions.
Chong Kun Dang Pharmaceutical Corp. dividend yield was 1.18% in 2024, and payout ratio reached 12.80%. The year before the numbers were 0.80% and 6.27% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Chong Kun Dang Pharmaceutical Corp. EBITDA is 107.71 B KRW, and current EBITDA margin is 8.78%. See more stats in Chong Kun Dang Pharmaceutical Corp. financial statements.
Like other stocks, 185750 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Chong Kun Dang Pharmaceutical Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Chong Kun Dang Pharmaceutical Corp. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Chong Kun Dang Pharmaceutical Corp. stock shows the neutral signal. See more of Chong Kun Dang Pharmaceutical Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.